Scott Lindhorst

4.0k total citations · 1 hit paper
28 papers, 609 citations indexed

About

Scott Lindhorst is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Scott Lindhorst has authored 28 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 11 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Scott Lindhorst's work include Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (6 papers) and Cancer Mechanisms and Therapy (3 papers). Scott Lindhorst is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (6 papers) and Cancer Mechanisms and Therapy (3 papers). Scott Lindhorst collaborates with scholars based in United States and Canada. Scott Lindhorst's co-authors include Arabinda Das, Sunil J. Patel, Abhay Varma, William A. Vandergrift, David Cachia, Pierre Giglio, Naren L. Banik, Cynthia T. Welsh, Donna R. Roberts and B.H. Thiers and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Scott Lindhorst

28 papers receiving 600 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma

2022 104 citations Christina Tsien, Stephanie L. Pugh et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Scott Lindhorst

Since Specialization

Citations

This map shows the geographic impact of Scott Lindhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Lindhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Lindhorst more than expected).

Fields of papers citing papers by Scott Lindhorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Lindhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Lindhorst. The network helps show where Scott Lindhorst may publish in the future.

Co-authorship network of co-authors of Scott Lindhorst

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Lindhorst. A scholar is included among the top collaborators of Scott Lindhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Lindhorst. Scott Lindhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy 2025 ·Cancers ·(unknown), M. S. Zobaer, (unknown), Angela Alexander-Bryant, (unknown), (unknown), Arabinda Das, William A. Vandergrift, (unknown), Alicia Zukas, Scott Lindhorst, Sunil J. Patel, Ben A. Strickland, Nathan C. Rowland	3
2	NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma breakdown → 2022 ·Journal of Clinical Oncology ·Christina Tsien, Stephanie L. Pugh, Adam P. Dicker, Jeffrey J. Raizer, M.M. Matuszak, Enrico C. Lallana, Jiayi Huang, Özer Algan, Nimisha Deb, Lorraine Portelance, John L. Villano, John Hamm, Kevin Oh, Arif N. Ali, Michelle M. Kim, Scott Lindhorst, Minesh P. Mehta	104
3	Establishing a Standardized Method for the Effective Intraoperative Collection and Biological Preservation of Brain Tumor Tissue Samples Using a Novel Tissue Preservation System: A Pilot Study 2022 ·World Neurosurgery ·Arabinda Das, (unknown), Heather R. Stephens, (unknown), Scott Lindhorst, David Cachia, Sunil J. Patel, Bruce Frankel	1
4	Case report: Awake craniotomy during pregnancy for resection of glioblastoma 2022 ·Clinical Neurology and Neurosurgery ·(unknown), (unknown), Arabinda Das, Christina Voelkel‐Johnson, Sunil J. Patel, Scott Lindhorst, Milad Yazdani, (unknown), Nathan C. Rowland	6
5	Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations 2020 ·Clinical & Translational Oncology ·Arabinda Das, Mohammed Alshareef, (unknown), Guilherme Porto, D. G. McDonald, (unknown), William A. Vandergrift, Scott Lindhorst, Abhay Varma, Sunil J. Patel, David Cachia	14
6	Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment 2020 ·Journal of the Neurological Sciences ·Arabinda Das, Mohammed Alshareef, Guilherme Porto, (unknown), William A. Vandergrift, Scott Lindhorst, Abhay Varma, Sunil J. Patel, David Cachia	4
7	MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells 2020 ·Clinical & Translational Oncology ·Arabinda Das, Fraser Henderson, Mohammed Alshareef, Guilherme Porto, (unknown), (unknown), William A. Vandergrift, Scott Lindhorst, Abhay Varma, Sunil J. Patel, David Cachia	12
8	CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539 2020 ·Neuro-Oncology ·Leland Rogers, Stephanie L. Pugh, Michael A. Vogelbaum, Arie Perry, Lynn S. Ashby, Jignesh Modi, Anthony M. Alleman, Emad Youssef, Steve Braunstein, Joseph Bovi, John de Groot, Anthony Whitton, Scott Lindhorst, Nicholas F. Taylor, Dennis C. Shrieve, Hui‐Kuo G. Shu, Mitchell Machtay, Mark V. Mishra, Clifford G. Robinson, Minesh P. Mehta	4
9	Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma 2020 ·Neuro-Oncology Advances ·(unknown), (unknown), Adrian M. Dubuc, Cynthia T. Welsh, (unknown), Linda D. Cooley, Midhat S. Farooqi, Stuart Schwartz, Yvonne Y. Li, Andrew D. Cherniack, Scott Lindhorst, (unknown), Daynna J. Wolff, David M. Meredith	12
10	Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth 2019 ·Clinical & Translational Oncology ·Arabinda Das, Mohammed Alshareef, Fraser Henderson, (unknown), William A. Vandergrift, Scott Lindhorst, Abhay Varma, (unknown), Sunil J. Patel, David Cachia	23
11	Clinical characteristics, EEG findings and implications of status epilepticus in patients with brain metastases 2019 ·Journal of the Neurological Sciences ·(unknown), Shaun Ajinkya, (unknown), (unknown), Alain Lekoubou, Scott Lindhorst, David Cachia, Adriana Olar, Ekrem Kutluay	2
12	Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features 2019 ·Journal of the Neurological Sciences ·(unknown), Shaun Ajinkya, (unknown), Scott Lindhorst, David Cachia, Adriana Olar, Ekrem Kutluay	9
13	Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma 2018 ·Cancer Chemotherapy and Pharmacology ·Arabinda Das, Fraser Henderson, Stephen Lowe, Gerald Wallace, William A. Vandergrift, Scott Lindhorst, Abhay Varma, (unknown), Pierre Giglio, (unknown), Sunil J. Patel, David Cachia	16
14	High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function 2016 ·Investigative Radiology ·Donna R. Roberts, Scott Lindhorst, Cynthia T. Welsh, Kenneth R. Maravilla, (unknown), (unknown), B.H. Thiers, Warren Davis	112
15	A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway 2015 ·Tumor Biology ·Arabinda Das, (unknown), Philip Lee, (unknown), Scott Lindhorst, Jerry J. Jaboin, William A. Vandergrift, Naren L. Banik, Pierre Giglio, Abhay Varma, Jeffery J. Raizer, Sunil J. Patel	43
16	RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma 2015 ·Tumor Biology ·Arabinda Das, D. G. McDonald, (unknown), D Jacqmin, (unknown), William A. Vandergrift, Scott Lindhorst, David Cachia, Abhay Varma, Kenneth N. Vanek, Naren L. Banik, Joseph M. Jenrette, Jeffery J. Raizer, Pierre Giglio, Sunil J. Patel	38
17	Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy. 2015 ·PubMed ·Philip Lee, (unknown), (unknown), Vivek Menon, Naren L. Banik, Pierre Giglio, Scott Lindhorst, Abhay Varma, William A. Vandergrift, Sunil J. Patel, Arabinda Das	69
18	Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma 2015 ·SHILAP Revista de lepidopterología ·Arabinda Das, (unknown), (unknown), (unknown), (unknown), (unknown), Naren L. Banik, Scott Lindhorst, David Cachia, Abhay Varma, Sunil J. Patel, Pierre Giglio	26
19	An Unusual Presentation of Chronic Myelogenous Leukemia: A Review of Isolated Central Nervous System Relapse 2013 ·Journal of the National Comprehensive Cancer Network ·Scott Lindhorst, Richard D. Lopez, (unknown)	9
20	Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis? 2006 ·Nature Clinical Practice Neurology ·Scott Lindhorst, Merit Cudkowicz	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact